205 related articles for article (PubMed ID: 3861603)
21. Phase I and II agents in cancer therapy: I. Anthracyclines and related compounds.
Wadler S; Fuks JZ; Wiernik PH
J Clin Pharmacol; 1986; 26(7):491-509. PubMed ID: 2944917
[TBL] [Abstract][Full Text] [Related]
22. 3'-deamino-3'-morpholino derivatives of daunomycin, adriamycin and carminomycin.
Takahashi Y; Kinoshita M; Masuda T; Tatsuta K; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1982 Jan; 35(1):117-8. PubMed ID: 7068512
[No Abstract] [Full Text] [Related]
23. Synthesis and antitumor activity of 3'-C-methyl-daunorubicin.
Thang TT; Imbach JL; Fizames C; Lavelle F; Ponsinet G; Olesker A; Lukacs G
Carbohydr Res; 1985 Jan; 135(2):241-7. PubMed ID: 3986844
[TBL] [Abstract][Full Text] [Related]
24. New anthracycline glycosides: 4-O-demethyl-11-deoxydoxorubicin and analogues from Streptomyces peucetius var. aureus.
Cassinelli G; Rivola G; Ruggieri D; Arcamone F; Grein A; Merli S; Spalla C; Casazza AM; Di Marco A; Pratesi G
J Antibiot (Tokyo); 1982 Feb; 35(2):176-83. PubMed ID: 6951826
[TBL] [Abstract][Full Text] [Related]
25. Adriamycin analogues. Novel anomeric ribofuranoside analogues of daunorubicin.
Israel M; Airey JE; Murray RJ; Gillard JW
J Med Chem; 1982 Jan; 25(1):28-31. PubMed ID: 7086818
[TBL] [Abstract][Full Text] [Related]
26. Future clinical investigations with anthracycline antibiotics in relation to daunorubicin.
Muggia FM; Blum RH; Wernz JC
Cancer Treat Rep; 1981; 65 Suppl 4():35-7. PubMed ID: 6955012
[TBL] [Abstract][Full Text] [Related]
27. Markedly reduced levels of anthracycline-induced DNA strand breaks in resistant P388 leukemia cells and isolated nuclei.
Capranico G; Riva A; Tinelli S; Dasdia T; Zunino F
Cancer Res; 1987 Jul; 47(14):3752-6. PubMed ID: 3474061
[TBL] [Abstract][Full Text] [Related]
28. Adriamycin analogues. Preparation of 7-O-(D-ribofuranosyl)-daunomycinone and -adriamycinone.
Kumar N; Seshadri R; Israel M
Carbohydr Res; 1986 Sep; 153(1):171-80. PubMed ID: 3779691
[No Abstract] [Full Text] [Related]
29. Chemical modification of anthracycline antibiotics IV. Synthesis of new anthracyclines with trisaccharide.
Tanaka H; Yoshioka T; Shimauchi Y; Matsushita Y; Matsuzawa Y; Oki T; Ishikura T
J Antibiot (Tokyo); 1982 Mar; 35(3):312-20. PubMed ID: 6951827
[TBL] [Abstract][Full Text] [Related]
30. Antitumour activity of new semi-synthetic anthracyclines containing fluorotalopyranose.
Umezawa K; Takeuchi T; Komuro K; Nosaka C; Kunimoto S; Tsuchiya T; Takagi Y; Umezawa S; Umezawa H
Drugs Exp Clin Res; 1988; 14(7):429-34. PubMed ID: 3240703
[TBL] [Abstract][Full Text] [Related]
31. [Antitumor antibiotics of the anthracycline series and their semisynthetic derivatives].
Povarov LS
Antibiotiki; 1977 Jul; 22(7):653-67. PubMed ID: 883809
[No Abstract] [Full Text] [Related]
32. New antitumor anthracyclines.
Arcamone F
Lloydia; 1977; 40(1):45-66. PubMed ID: 875639
[No Abstract] [Full Text] [Related]
33. Syntheses and antitumor activities of 7-O-(6-deoxy-2-O-methyl-alpha-L-talopyranosyl)-daunomycinone and -adriamycinone.
Takagi Y; Kobayashi N; Tsuchiya T; Umezawa S; Takeuchi T; Komuro K; Nosaka C
J Antibiot (Tokyo); 1989 Aug; 42(8):1318-20. PubMed ID: 2759915
[No Abstract] [Full Text] [Related]
34. Synthesis and antitumor activity of 4'-O-methyldaunorubicin, 4'-O-methyladriamycin, and their 4'-epi analogues.
Cassinelli G; Ruggieri D; Arcamone F
J Med Chem; 1979 Feb; 22(2):121-3. PubMed ID: 423191
[No Abstract] [Full Text] [Related]
35. DNA topoisomerase II-mediated interaction of doxorubicin and daunorubicin congeners with DNA.
Bodley A; Liu LF; Israel M; Seshadri R; Koseki Y; Giuliani FC; Kirschenbaum S; Silber R; Potmesil M
Cancer Res; 1989 Nov; 49(21):5969-78. PubMed ID: 2551497
[TBL] [Abstract][Full Text] [Related]
36. 14-esters of 7-O-(3,4-di-O-acetyl-2,6-dideoxy-alpha-L-lyxo-hexopyranosyl)adriamycinone: synthesis and antitumor activity.
Horton D; Priebe W
J Antibiot (Tokyo); 1983 Sep; 36(9):1211-5. PubMed ID: 6630080
[TBL] [Abstract][Full Text] [Related]
37. Intensely potent morpholinyl anthracyclines.
Acton EM; Tong GL; Mosher CW; Wolgemuth RL
J Med Chem; 1984 May; 27(5):638-45. PubMed ID: 6716401
[TBL] [Abstract][Full Text] [Related]
38. [Derivatives of antineoplastic antibiotics of the daunorubicin series containing methylurea or nitrosomethylurea residues].
Povarov LS; Bakina EV; Lazhko EI; Orlova GI; Zhukova OS; Obidniak NA; Iurchenko GI; Glazkova TIu; Preobrazhenskaia MN
Bioorg Khim; 1990 Apr; 16(4):559-68. PubMed ID: 2375780
[TBL] [Abstract][Full Text] [Related]
39. Adriamycin analogues. Preparation and biological evaluation of some N-perfluoroacyl analogues of daunorubicin, adriamycin, and N-(trifluoroacetyl)adriamycin 14-valerate and their 9,10-anhydro derivatives.
Israel M; Potti G
J Med Chem; 1982 Feb; 25(2):187-91. PubMed ID: 7057426
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and antitumor activity of novel 4-demethoxyanthracyclines.
Adams N; Blake C; Broadhurst MJ; Bushnell DJ; Hassall CH; Hartmann HR; Keech E; Stratton AR; Thomas GJ
J Med Chem; 1990 Sep; 33(9):2375-9. PubMed ID: 2391681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
